홈
탐색
nav.journalClub
트렌드
더보기
synapse
⌘+K
언어
한국어
Galectin-3 in AKI: Pathogenic Target, Diagnostic Biomarker, or Both? | Synapse
March 3, 2026
Open Access
Galectin-3 in AKI: Pathogenic Target, Diagnostic Biomarker, or Both?
YG
Yuan Gui
University of Connecticut
DZ
Dong Zhou
University of Connecticut
Key Points
Galectin-3 plays a significant role in the pathogenesis of acute kidney injury, influencing inflammation.
Levels of galectin-3 can be used as a diagnostic biomarker to assess kidney injury severity.
Analysis of clinical data indicates a correlation between elevated galectin-3 levels and poorer outcomes in acute kidney injury.
Identifying galectin-3 as both a pathogenic target and a biomarker highlights its potential for improved management of kidney health.
Read Full Paper
with AI
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper
Cite This Study
Copy
Gui et al. (Thu,) studied this question.
synapsesocial.com/papers/69a76118c6e9836116a2eaf8
https://doi.org/https://doi.org/10.7150/ijbs.129063
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper